| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e67818ab2d3b97121031ecfbb559e1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2006-80 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G28-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 |
| filingDate |
2017-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c3b5dfa897f5a7b1f258a807ce6b0bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c39089f2b7cae5a767a564e1d6a58f10 |
| publicationDate |
2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2019005737-A |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION TO PREVENT OR TREAT BRAIN CANCER INCLUDING POLYMORPHOCRISTALINE TETRAARSENIC HEXAOXIDE AND METHOD TO PREPARE THE SAME. |
| abstract |
The present invention relates to a pharmaceutical composition which is for preventing or treating brain cancer and includes at least 99% of a crystalline polymorph of tetraarsenic hexaoxide a (As4O6-a), and with a method for preparing the same. A composition according to the present invention exhibits excellent cancer cell proliferation inhibition and metastasis inhibition effects, and thus can be usefully used as an anticancer agent. |
| priorityDate |
2016-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |